H.R. 6110 · 115th Congress
Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018'
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the House without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 115th Congress ended.
R
WalorskiSponsor9 cosponsors · 4 D, 5 R
D
Blumenauer
JC
D
Chu
DD
D
Davis
KM
R
Marchant
TM
R
MacArthur
KN
R
Noem
PR
R
Roskam
KR
R
Rothfus
LS
D
Sánchez9 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced Jun 14, 2018
- House Passed Jun 19, 2018
Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018
What it does: CRS summary · Passed House without amendment · Jun 19, 2018
Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018
This bill establishes several requirements for the Centers for Medicare & Medicaid Services (CMS), and alters requirements under Medicare and Medicare Advantage (MA), related to pain management and opioid use.
Among other requirements, the CMS must review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly.
The bill also requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment (e.g., buprenorphine).
The bill also authorizes the suspension of payments to a pharmacy under the Medicare prescription drug benefit and MA prescription drug plans pending the investigation of a credible allegation of fraud by the pharmacy.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Dr. Todd Graham Pain Management, Treatment, and Recovery Act of 2018
Latest action (Jun 25, 2018): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jun 14, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- House Introduced Jun 14, 2018
- House Passed Jun 19, 2018
No recorded floor vote found.